abstract |
The present invention provides quinazoline compounds of formula (I) for treating JAK kinase-mediated diseases (including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases). Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions. |